Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 16 of 16 entries
Sorted by: Best Match Show Resources per page
Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues.

Scientific reports

Hojny J, Michalkova R, Krkavcova E, Bui QH, Bartu M, Nemejcova K, Kalousova M, Kleiblova P, Dundr P, Struzinska I.
PMID: 34997048
Sci Rep. 2022 Jan 07;12(1):199. doi: 10.1038/s41598-021-03989-z.

Hepatocyte nuclear factor-1-beta (HNF1B) is a transcription factor and putative biomarker of solid tumours. Recently, we have revealed a variety of HNF1B mRNA alternative splicing variants (ASVs) with unknown, but potentially regulatory, functions. The aim of our work was...

Cite
Hojny J, Michalkova R, Krkavcova E, et al. Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues. Sci Rep. 2022;12(1):199doi: 10.1038/s41598-021-03989-z.
Hojny, J., Michalkova, R., Krkavcova, E., Bui, Q. H., Bartu, M., Nemejcova, K., Kalousova, M., Kleiblova, P., Dundr, P., & Struzinska, I. (2022). Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues. Scientific reports, 12(1), 199. https://doi.org/10.1038/s41598-021-03989-z
Hojny, Jan, et al. "Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues." Scientific reports vol. 12,1 (2022): 199. doi: https://doi.org/10.1038/s41598-021-03989-z
Hojny J, Michalkova R, Krkavcova E, Bui QH, Bartu M, Nemejcova K, Kalousova M, Kleiblova P, Dundr P, Struzinska I. Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues. Sci Rep. 2022 Jan 07;12(1):199. doi: 10.1038/s41598-021-03989-z. PMID: 34997048.
Copy Download .nbib Format: NLM
Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Salzano G, Passanisi S, Mammì C, Priolo M, Pintomalli L, Caminiti L, Messina MF, Pajno GB, Lombardo F.
PMID: 31098941
Diabetes Ther. 2019 Aug;10(4):1543-1548. doi: 10.1007/s13300-019-0633-3. Epub 2019 May 16.

Maturity onset diabetes of the young (MODY) accounts for up to 4% of all cases of diabetes in pediatric patients. MODY is usually characterized by autosomal dominant inheritance, impaired insulin secretion, and an average age at diagnosis of 18-26...

Cite
Salzano G, Passanisi S, Mammì C, et al. Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation. Diabetes Ther. 2019;10(4):1543-1548doi: 10.1007/s13300-019-0633-3.
Salzano, G., Passanisi, S., Mammì, C., Priolo, M., Pintomalli, L., Caminiti, L., Messina, M. F., Pajno, G. B., & Lombardo, F. (2019). Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation. Diabetes therapy : research, treatment and education of diabetes and related disorders, 10(4), 1543-1548. https://doi.org/10.1007/s13300-019-0633-3
Salzano, Giuseppina, et al. "Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 10,4 (2019): 1543-1548. doi: https://doi.org/10.1007/s13300-019-0633-3
Salzano G, Passanisi S, Mammì C, Priolo M, Pintomalli L, Caminiti L, Messina MF, Pajno GB, Lombardo F. Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation. Diabetes Ther. 2019 Aug;10(4):1543-1548. doi: 10.1007/s13300-019-0633-3. Epub 2019 May 16. PMID: 31098941; PMCID: PMC6612332.
Copy Download .nbib Format: NLM
The HNF-1β-USP28-Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma.

Oncotarget

Ito F, Yoshimoto C, Yamada Y, Sudo T, Kobayashi H.
PMID: 29707125
Oncotarget. 2018 Apr 03;9(25):17512-17522. doi: 10.18632/oncotarget.24776. eCollection 2018 Apr 03.

Transcription factor hepatocyte nuclear factor 1-beta (HNF-1β) enhances checkpoint kinase 1 (Chk1) activation and promotes G2/M cell cycle progression in ovarian clear cell carcinoma (CCC) following exposure to diverse genotoxic agents including bleomycin. However, the underlying mechanism leading to...

Cite
Ito F, Yoshimoto C, Yamada Y, et al. The HNF-1β-USP28-Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma. Oncotarget. 2018;9(25):17512-17522doi: 10.18632/oncotarget.24776.
Ito, F., Yoshimoto, C., Yamada, Y., Sudo, T., & Kobayashi, H. (2018). The HNF-1β-USP28-Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma. Oncotarget, 9(25), 17512-17522. https://doi.org/10.18632/oncotarget.24776
Ito, Fuminori, et al. "The HNF-1β-USP28-Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma." Oncotarget vol. 9,25 (2018): 17512-17522. doi: https://doi.org/10.18632/oncotarget.24776
Ito F, Yoshimoto C, Yamada Y, Sudo T, Kobayashi H. The HNF-1β-USP28-Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma. Oncotarget. 2018 Apr 03;9(25):17512-17522. doi: 10.18632/oncotarget.24776. eCollection 2018 Apr 03. PMID: 29707125; PMCID: PMC5915133.
Copy Download .nbib Format: NLM
The Expression of Transcription Factors in Fetal Lamb Kidney.

Journal of developmental biology

Nishiya Y, Kawaguchi K, Kudo K, Kawaguchi T, Obayashi J, Tanaka K, Ohyama K, Nagae H, Furuta S, Seki Y, Koike J, Pringle KC, Kitagawa H.
PMID: 34205452
J Dev Biol. 2021 Jun 19;9(2). doi: 10.3390/jdb9020022.

(1) Background: Renal development involves frequent expression and loss of transcription factors, resulting in the activation of genes. Wilms' tumor 1 (WT1), hepatocyte nuclear factor-1-beta (HNF1β), and paired box genes 2 and 8 (Pax2 and Pax8) play an important...

Cite
Nishiya Y, Kawaguchi K, Kudo K, et al. The Expression of Transcription Factors in Fetal Lamb Kidney. J Dev Biol. 2021;9(2)doi: 10.3390/jdb9020022.
Nishiya, Y., Kawaguchi, K., Kudo, K., Kawaguchi, T., Obayashi, J., Tanaka, K., Ohyama, K., Nagae, H., Furuta, S., Seki, Y., Koike, J., Pringle, K. C., & Kitagawa, H. (2021). The Expression of Transcription Factors in Fetal Lamb Kidney. Journal of developmental biology, 9(2), . https://doi.org/10.3390/jdb9020022
Nishiya, Yuri, et al. "The Expression of Transcription Factors in Fetal Lamb Kidney." Journal of developmental biology vol. 9,2 (2021). doi: https://doi.org/10.3390/jdb9020022
Nishiya Y, Kawaguchi K, Kudo K, Kawaguchi T, Obayashi J, Tanaka K, Ohyama K, Nagae H, Furuta S, Seki Y, Koike J, Pringle KC, Kitagawa H. The Expression of Transcription Factors in Fetal Lamb Kidney. J Dev Biol. 2021 Jun 19;9(2). doi: 10.3390/jdb9020022. PMID: 34205452; PMCID: PMC8293116.
Copy Download .nbib Format: NLM
Showing 13 to 16 of 16 entries